Showing results (791-800 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|September 2, 2025
Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizuresRiccardo Pascuzzo, Roberta Rudà, Peter B Barker, et al.
Neuro-Oncology Advances|September 3, 2025
Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade gliomaAbiola A Ayanlaja, Michael Chang, Kriti Lalwani, et al.
Neuro-Oncology Advances|May 20, 2021
Receptor-driven invasion profiles in diffuse intrinsic pontine gliomaAnju Karki, Noah E Berlow, Jin-Ah Kim, et al.
Neuro-Oncology Advances|August 19, 2021
A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade gliomaKendall L Hughes, Christen M O'Neal, Bethany J Andrews, et al.
Neuro-Oncology Advances|August 4, 2021
Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentationHuy Gia Vuong, Tam N M Ngo, Ian F Dunn
Neuro-Oncology Advances|August 6, 2021
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversyMasayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, et al.
Neuro-Oncology Advances|August 6, 2021
Preoperative imaging of glioblastoma patients using hyperpolarized 13C pyruvate: Potential role in clinical decision makingJun Chen, Toral R Patel, Marco C Pinho, et al.
Neuro-Oncology Advances|May 12, 2021
MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international studyLydia T Tam, Kristen W Yeom, Jason N Wright, et al.
Neuro-Oncology Advances|August 22, 2022
The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic reviewKyra X Swildens, Peter A E Sillevis Smitt, Martin J van den Bent, et al.
Pageof 138